Danny May
About Danny May
Danny May serves as the Director of Clinical Vendor Alliance Management in Development Operations at Insmed Incorporated, where he has worked since 2022. He has extensive experience in managing complex global clinical trials and specialty labs, with a background that includes various roles at Synteract and a focus on rare diseases and respiratory conditions.
Current Role at Insmed
Danny May currently serves as the Director of Clinical Vendor Alliance Management in Development Operations at Insmed Incorporated. He has held this position since 2022, contributing to the management of clinical vendor relationships and operational strategies. His role involves overseeing complex clinical trials and ensuring effective collaboration with various vendors.
Previous Experience at Insmed
Prior to his current role, Danny May worked at Insmed Incorporated in various capacities. He served as the Associate Director of Clinical Operations from 2019 to 2022, focusing on managing clinical trials remotely. Additionally, he held the position of Manager of Clinical Operations - Specialty Vendor Oversight from 2018 to 2019, where he was responsible for overseeing specialty vendors in clinical operations.
Experience at Synteract
Danny May has extensive experience at Synteract, where he held multiple roles over several years. He worked as a Senior Project Manager from 2014 to 2017, and as a Project Director for 11 months in 2017. His earlier roles included Clinical Project Manager from 2010 to 2014 and Senior Clinical Data Manager from 2007 to 2010. His positions involved managing data and project operations in clinical trials.
Education and Expertise
Danny May studied General Studies at California State University San Marcos and pursued Psychology at Ashford University, where he earned a Bachelor of Arts degree. He also attended the University of Nevada-Las Vegas. His expertise includes managing and mitigating risks in global clinical trials, particularly in high-complexity environments, and he has experience with specialty labs and core labs.
Focus Areas in Clinical Research
Danny May has a specific focus on non-tuberculous mycobacterial (NTM) diseases, rare diseases, and respiratory conditions. His involvement in ePRO and ethnobridging studies highlights his commitment to advancing clinical research in these areas. He is experienced in managing various lab specialties, including Microbiology, pharmacokinetics/pharmacodynamics (PK/PD), ECG, pulmonary function tests (PFT), and CT scans.